NEW YORK, Sept. 19 – Bayer and Millennium Pharmaceuticals said Wednesday they had extended their alliance to look for new drug targets to battle thrombosis, urinary incontinence, and benign prostatic hypertrophy. 

The companies, which began working together in 1998 and have until now focused on cardiovascular diseased, cancer, pain, hematology, and viral infections, said they have so far identified more than 140 potential drug targets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.